When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRVB - Provention Bio: The First Type 1 Diabetes Breakthrough In A 100 Years
Provention Bio Inc.
Provention Bio (PRVB) is a small-cap biotech company focused on developing drugs to combat autoimmune diseases – in particular, Type 1 diabetes (T1D).
At the time of writing, it trades at a share price of $9.85, giving a market cap of $470m and an enterprise value of roughly $385m. I believe this market valuation greatly undervalues the true potential of the company – in fact, I’d go as far as to say it’s the best risk/reward play I have come across in my recent research - and will explain why below.